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1. Introduction
 
   Globally many countries committed to achieving 
universal access to HIV prevention, treatment, care and 
support for all in need by 2010. Significant progress has 
been made. By the end of 2009, an estimated 5.25 million 
person in low- and middle-income countries were 
receiving life-prolong antiretroviral therapy. But, it still 
need more efforts to eliminate stigma and discrimination 
related to HIV transmission, gender, sex work, drug 
use and homosexuality mark key steps to realize zero 
discrimination in the context of HIV[1,2].
   HIV remains a dominant health threat in most of sub-
Saharan Africa. Many countries with low HIV prevalence 
have raging epidemics concentrated among men who have 
sex with men, transgender people, sex workers and their 
clients and/or people who use drugs[3]. 
   Stigma remains the single most important barrier to public 
action. The epidemic of fear, stigmatization and discrimination 
has undermined the ability of individuals, families and 
societies to protect themselves and provide support and 
reassurance to those affected. It complicates decisions about 
testing, disclosure of status, and ability to negotiate prevention 
behaviours and taking antiretroviral drugs[4,5]. 
   HIV-positive individuals continue to engage in unsafe 
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sexual and drug-sharing behaviours without sero-status 
disclosure, which hinders HIV prevention efforts. The 
disease progression theory suggests that some sero-positive 
individuals’ decisions to disclose their status occur when 
the disease progresses to AIDS, because they can no longer 
hide the disease or keep it secret[6].
   Disclosure of an HIV-positive sero-status to a sex partner 
offers informed decision making opportunities. Intra- 
and interpersonal factors, including efficacy beliefs and 
relationship status are clearly related to the decisions to 
disclose. In casual relationships, women may feel that it 
is easier to engage in sex rather than to talk about it. The 
use of interventions that strengthens efficacy appraisals 
especially in relation to knowing when it is safe to disclose 
is warranted[7].
   According to Ethiopia Demographic and Health Survey 
in 2011, 1.5% of adults age 15-49 are infected with HIV 
and heterosexual contact accounts for the great majority 
of HIV transmission in the country. Widespread stigma 
and discrimination towards people infected with HIV 
adversely affect both people’s willingness to be tested 
for HIV, disclosure and their adherence to antiretroviral 
therapy. Thus, to increase self-efficacy for HIV sero-
status disclosure decisions and safer sex in HIV sero-
positive people is an important indicator of the success of 
programmes to prevent and control HIV/AIDS[8].
   In Ethiopia, there is no documented information about 
self-efficacy for HIV sero-status disclosure decisions and 
safer sex in HIV sero-positive people until the time of this 
study. Therefore, this study helps to determine the self-
efficacy for HIV sero-status disclosure decisions and safer 
sex in HIV sero-positive people.
2. Methods and materials
2.1. Study area and period
   Facility based cross sectional survey was conducted 
from January 1 to February 28, 2013 in Jimma University 
Specialized Hospital (JUSH), Jimma town, Southwest 
Ethiopia, which is located 346 km from Addis Ababa. JUSH is 
the only teaching and referral hospital in the southwestern 
part of the country. It provides specialized health services 
through its 9 medical and other clinical and diagnostic 
departments for approximately 9 000 inpatients and 80 000 
outpatients each year with bed capacity of 434 (surgical 
wards: 128; medical wards: 90; gynecology and maternity 
wards: 70; pediatrics: 86; psychiatry: 20; and ophthalmology 
wards: 40). Its healthcare work force is composed of more 
than 550 professionals of different disciplines. In 2012, 
the total number of people who registered on Assisted 
Reproductive Technology (ART) clinic was 6 278. 
   Source population: All HIV positive people who follow up 
in ART Clinic, JUSH.  
   Study population: Sampled HIV positive people who follow 
up in ART clinic, JUSH.  
   Sample size determination: the sample size is determined 
by using a single proportion formula, assuming P=the 
proportion of self-efficacy for disclosure and safe sex. But 
it is unknown, so took the value (50%) that gives a maximum 
sample size for the study. 
   D=margin of error=1%, Confidence interval (CI)=99%, since 
the issue is too sensitive, we tolerate 1% error. Therefore, 
the final sample size with 10% non-response rate is 601.
2.2. Sampling techniques/procedures
   Simple random sampling technique was used to select 
study participants from a list of registration book. 
2.3. Measurements
   A structured English questionnaire was adapted from 
similar studies. The questionnaire has different sub-
sections include socio-demographic, self-efficacy of 
disclosure decision, self-efficacy of safer sex, self-efficacy 
in HIV treatment adherence, disclosure experience and safe 
sex behavior. The specific behavioral items are: (1) How 
confident are you that you could make an effective decision 
of whether to telling this person you are HIV positive in 
this situation? (2) How confident are you that you could 
know whether it was safe to tell this person in this situation 
that you are HIV positive? (3) How confident are you that 
you could bring up the need to practice safer sex in this 
situation? (4) How confident are you that you would refuse 
to have unsafe sex in this situation even if your partner 
pressures you to be unsafe?
   Thus, we obtained 4 self-efficacy scores: make an 
effective disclosure decision to know whether it was safe to 
disclose, bring up the need to practice safer sex and refuse 
to have unsafe sex. Self-efficacy of disclosure decision 
and self-efficacy of safer sex were summed across the 
first 8 stories. The story is then repeated with some details 
changed to make it different. There are 8 sets of stories. 
How confident they are that they could perform an action 
by circling their rating from 1=cannot do at all, 2=somewhat 
certain can do and 3=certain can do. Both disclosure 
experience and safe sex behavior items are included yes/no, 
alternatives and scale[9,10]. All 4 self-efficacy of disclosure 
decision and self-efficacy of safer sex item for each taken 
together yield a maximum score of 12 and a minimum of 
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4. Self-efficacy in HIV treatment adherence has 12 items. 
Higher score on each item indicates higher level of self-
efficacy.
2.4. Data collection techniques
   Data were collected using pre-tested interviewer-
administered questionnaire. All participated data collectors 
and supervisors had a BSc qualification in nursing and 
health education. Before the actual data collection, the 
questionnaire was tested on 5% of the total samples. The 
study participants that take part in the pre-test were 
include in the main study. The pre-test was conducted in 
Jimma Health Center.
2.5. Data quality control
   The data collectors were introduced themselves and the 
purpose of the study to study participants. Questionnaires 
are adapted from similar studies and modified based on 
our objective to assure the quality of the data. The experts 
assured the content validity of the questionnaire. Training 
the data collectors and supervisors; Close supervision will 
be conducted. The questionnaire was also pre-tested on 
pilot area. The quality of the data was also assured through 
explained unclear idea during data collection, completeness 
check and consistency of the filled questionnaire. The data 
was clearned and analyzed in appropriate analysis.
2.6. Data analysis
   The data were entered into statistical package for social 
sciences version 16.0. The data were edited and cleaned 
for inconsistencies, completeness. Descriptive analysis 
was done to describe the characteristics of the study 
participants. Correlations were computed among the 4 
self-efficacy scales. Construct validity was computed to 
see associations between self-efficacy scales and targeted 
behaviors (disclosure and safe sex). The mean score of the 
scales will be computed to make an effective disclosure 
decision to know whether it was safe to disclose, bring up 
the need to practice safer sex and refuse to have unsafe 
sex. Logistic regression was used to know the predictor 
of disclosure. Finally, independent variables which had 
statistically significant association with the dependent 
variable (P<0.05) will be entered to the final multiple 
logistic regression models.
2.7. Ethical consideration
   Ethical clearance will be obtained from ethical clearance 
committee of college of public health and medical science 
of Jimma University. After getting the ethical clearance, 
written permission will be obtained from JUSH and verbal 
informed consents will be obtained from each study 
participants.
3. Results
3.1. Socio-demographic characteristics
   Out of 601 study participants, 591 were interviewed with 
a response rate of 98.3%. Regarding to sex, 401 (67.9%) were 
females and the mean age of the study participants were 
34.5依8.9 with a minimum of 20 years and maximum of 67 
years. Of the 591 study participants, 307 (51.9%) were orthodox 
in religion and 288 (48.7%) were Oromo in ethnicity (Table 1). 
Table 1
Frequency distribution on socio-demographic characteristics of HIV 
patients in JUSH, April 2013.
Variables (n=591) Frequency Percent (%)
Age 20-24  43  7.3
25-29 151 25.5
30-34 116 19.6
35-39 146 24.7
40-44  53  9.0
45-49  29  4.9
≥50  53  9.0
Sex Male 190 32.1
Female 401 67.9
Religion Orthodox 307 51.9
Muslim 180 30.5
Protestant 104 17.6
Ethnicity Oromo 288 48.7
Amhara 137 23.2
Gurage  19  3.2
Tigre  20  3.4
Dawro  75 12.7
Others#  52   8.8
Marital status Married 332 56.2
Divorced 103 17.4
Widowed  62 10.5
Single  94 15.9
Educational status Illiterate 107 18.1
Elementary school 153 25.9
Secondary school 155 26.2
College/University 176 29.8
Monthly income <450 116 22.8
450-600 122 24.0
601-900  99 19.4
901-1 300  72 14.1
>1 300 100 19.6
#: Kafficho, yem, Hadiya and Wolaita.
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3.2. Clinical characteristics
   Out of 601 study participants, 210 (38.6%) study participants 
had >500 cluster of differentiation 4 (CD4) counts. Regarding 
to treatment status, 578 (97.8%) were on ART. Of the 591 
study participants, 564 (95.4%) were disclosed their HIV 
status. Regarding reasons for disclosure, 356 (63.2%) study 
participants mentioned to get treatment. Of the 591 study 
participants, 300 (53.2%) were firstly disclosed their HIV 
status to their husband/partner (Table 2).
Table 2 
Frequency distribution on disclosure and treatment status of HIV 
patients in JUSH, April 2013.
Variables Frequency Percent (%)
CD4 count <200  53  9.7
200-350 134 24.6
351-500 147 27.0
>500 210  38.6
Total 544 100.0
Treatment 
status
Pre-ART  13    2.2
On-ART 578  97.8
Total 591 100.0
Disclosure 
status
Yes 564  95.4
No  27    4.6
Total 591 100.0
Reason for 
disclosure
To get support  49   8.7
To get treatment 356  63.2
The parents can also test 151  26.8
To avoid unwanted pregnancies   7    1.2
Total 563 100.0
To whom you 
first disclosed
Husband/Partner 300  53.2
Parents  72  12.8
Sibling  38    6.7
Children  31    5.5
Other relatives  12    2.1
Friends  26    4.6
Husband and parents  47    8.3
Parents and sibling  17    3.0
Parents and children   9    1.6
Sibling and children  12    2.1
Total 564 100.0
3.3. Perception on disclosure
   All the participants were asked which specific group 
is important to be disclosed (Table 3). Of the 588 study 
participants, 170 (28.9%), 280 (47.6%) and 273 (46.4%) were 
perceived that disclosing HIV status to boss/employers, 
close friends and casual friends are not important, 
respectively. But 431 (73.3%), 581 (98.8%) and 483 (82.1%) 
were perceived that disclosing HIV status to their children, 
health professionals and sexual partners are very important, 
respectively. 
Table 3
Perception of HIV patients on disclosure in JUSH, April 2013.
Variable (n=588) Respondence Frequency Percent (%)
Boss/employers Yes 170 28.9
No 418 71.1
Close friends Yes 280 47.6
No 308 52.4
Casual friends Yes 273 46.4
No 315 53.6
Brothers and sisters Yes 463 78.7
No 125 21.3
Children Yes 431 73.3
No 157 26.7
Health care providers Yes 581 98.8
No   7   1.2
Sexual partners Yes 483 82.1
No 105 17.9
3.4. Self-efficacy
   The mean score of self-efficacy on effective disclosure 
decision, self-efficacy on safe disclosure, self-efficacy on 
safe sex practice, self-efficacy on refusal of unsafe sex and 
self-efficacy on treatment adherence for HIV patients were 
4.6依1.9, 4.2依1.9, 2.6依1.4, 2.7依1.4 and 34.5依2.7, respectively.
3.5. Correlation of self-efficacy scales
   Self-efficacy on make an effective disclosure decision 
has linear correlation with self-efficacy on safe disclosure, 
self-efficacy on make an effective disclosure decision, self-
efficacy on safe sex practice and self-efficacy on treatment 
adherence (r=0.83, 0.11 and 0.12, P=0.01), respectively. Self-
efficacy on safe disclosure has linear correlation with self-
efficacy on safe sex practice, self-efficacy on refusal of 
unsafe sex and self-efficacy on treatment adherence (r=0.21, 
0.15 and 0.12, P=0.01). Self-efficacy on safe sex practice has 
linear correlation with self-efficacy on refusal of unsafe 
sex (r=0.92, P=0.01). Regarding to gender difference in self-
efficacy for disclosure decisions and negotiating safer sex, 
the statistical analysis showed that there was a significant 
association between gender and self-efficacy on make 
an effective disclosure decision; self-efficacy on safe 
disclosure; self-efficacy on safe sex practice; self-efficacy 
on refusal of unsafe sex and self-efficacy on treatment 
adherence at P<0.05. Of the 588 study participants, 375 
(63.8%) and 433 (73.6%) were aware of parents HIV status 
and had safe sexual practice respectively. Of the 581 study 
participants, 571 (98.3%) were not missing ART drug during 
treatment period (Table 4).
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Table 4
Frequency distribution on awareness, drug use and sexual behavior 
among HIV patients in JUSH, April 2013.
Variables Respondence Frequency Percent (%)
Aware of parents HIV status 
(n=588)
Yes 375 63.8
No 213 36.2
Save sexual behavior 
(n=588)
Yes 433 73.6
No 155 26.4
Missing ART drug 
(n=581)
Yes  10   1.7
No 571 98.3
3.6. Predictor of safe sex
   Logistic regression analysis was done to identify the effect 
of independent variables on sexual behavior, and this showed 
that married HIV patients [adjusted odds ratio (AOR), 95% 
CI)22.4 (8.6, 58.6)] were 22.4 times more likely practice safe 
sex than single HIV patients. HIV patients whose educational 
statuses were secondary school [AOR, 95% CI 0.5 (0.2, 0.9)] were 
0.5 times less likely practice safe sex than HIV patients whose 
educational statuses were college/university. HIV patients 
whose monthly income was between 901-1 300 [AOR, 95% CI 
0.2 (0.1, 0.7)] ETH Birr were 0.2 times less likely practice safe 
sex than HIV patients whose monthly income was above 1 300 
ETH Birr. A unit increase in total score of self-efficacy on safe 
disclosure the odds of practicing safe sex was reduced by 
0.6 [AOR, 95% CI 0.6 (0.5, 0.8)]. A unit increase in total score of 
self-efficacy on safe sex practice the odds of practicing safe 
sex was increased by 2.0 [AOR, 95% CI 2.0 (1.1, 3.8)] (Table 5).
Table 5
Multiple logistic regression analysis on associated factors of sexual behavior, 
April 2013.
Variables Sexual behavior AOR (95% CI)
Safe sex Unsafe sex
Current marital status Married 192 (57.8%) 140 (42.2%)  22.4 (8.6, 58.6)
*
Divorced   91 (91.0%)   9 (9.0%) 1.6 (0.5, 5.2)
Widowed      6 (100.0%) 0 0
Single   88 (93.6%)   6 (6.4%) 1
Educational status Illiterate   81 (75.7%)   26 (24.3%) 0.6 (0.3, 1.5)
Elementary school 127 (83.0%)   26 (17.0%) 0.6 (0.3, 1.4)
Secondary school 122 (78.7%)   33 (21.3%)    0.5 (0.2, 0.9)
**
College/University 103 (59.5%)   70 (40.5%) 1
Monthly income 
(ETH Birr)
<450   90 (77.6%)   26 (22.4%) 1.0 (0.4, 2.5)
450-600   91 (74.6%)   31 (25.4%) 0.8 (0.3, 1.8)
601-900   69 (69.7%)   30 (30.3%) 0.8 (0.4, 1.8)
901-1 300   60 (83.3%)   12 (16.7%)    0.2 (0.1, 0.7)
**
>1 300   55 (56.7%)   42 (43.3%) 1
Total score of self-efficacy on safe disclosure 4.56# 3.38#   0.6 (0.5, 0.8)*
Total score of self-efficacy on safe sex practice 2.63# 2.71#    2.0 (1.1, 3.8)**
#: Mean score; *: Significant at P<0.001; **: Significant at P<0.05.
4. Discussion
   This study provides insight to self-efficacy for disclosure 
decisions, self-efficacy for negotiating safer sex, self-
efficacy for treatment adherence, disclosure and sexual 
behavior of HIV patients in JUSH. The findings of this study 
showed that 38.6% study participants had >500 CD4 counts. 
This implies that the majority are not improving their 
immune status. Not improving their immune has a negative 
effect on quality of life. Ninety five percents of the study 
participants disclosed their HIV status. Regarding reasons 
for disclosure, 63.2% in the study participants mentioned to 
get treatment. This result is very high when compared with a 
study conducted in South Africa and Nigeria[11,12]. This may 
be due to differences between the two studies concerning 
accessibility of HIV service opportunities and awareness of 
participants about the importance of disclosure.
   The mean scores about self-efficacy on effective 
disclosure decision, self-efficacy on safe to disclosure, 
self-efficacy on safe sex practice, self-efficacy on refusal 
of unsafe sex and self-efficacy on treatment adherence for 
HIV patients were 4.6, 4.2, 2.6, 2.7 and 34.5, respectively. 
These imply that the study participants have high self-
efficacy on disclosure, safe sex and treatment adherence. 
When we see one by one, when the study participants have 
higher self-efficacy on effective disclosure decision, refusal 
of unsafe sex and treatment adherence as compare to other 
self-efficacy. This indicates that the success of HIV service 
in this community.
   Self-efficacy on making an effective disclosure decision 
has linear correlation with self-efficacy on safe to 
disclosure, self-efficacy on safe sex practice and self-
efficacy on treatment adherence, respectively. Self-efficacy 
on safe to disclosure has linear correlation with self-
efficacy on safe sex practice, self-efficacy on refusal of 
unsafe sex and self-efficacy on treatment adherence. Self-
efficacy on safe sex practice has linear correlation with 
self-efficacy on refusal of unsafe sex. These indicate that 
self-efficacy on safe to disclosure and safe sex practices 
have direct relationship. Giving disclosure on health service 
implies directly to inform the HIV patients about safe sex 
practice. This helps to achieve the goal of HIV prevention 
and control program. And this indicated the high rates in 
HIV patients of practicing preventive behavior as compared 
to individuals who had no self-efficacy.
   There is significant association between gender and self-
efficacy on make an effective disclosure decision; self-
efficacy on safe to disclosure; self-efficacy on safe sex 
practice; self-efficacy on refusal of unsafe sex and self-
efficacy on treatment adherence. This implies there is 
gender difference in self-efficacy for disclosure decisions 
and negotiating safer sex. So while designing self-efficacy 
program for HIV patients, Segmentation of audience (male 
and female) is very curial point to achieve the planned 
objective. 
   Sixty four and 73.6% of the study have awareness about 
their parents HIV status and had safe sexual practice 
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respectively. This result is low when compared with a study 
conducted other part of Ethiopia, Nigeria, Hawaii, Seattle 
and Washington[11-13]. The possible reason might be socio-
cultural difference and level of stigma and discrimination.  
   According to logistic regression analysis showed that 
married HIV patients were more likely practice safe sex than 
single HIV patients. HIV patients whose educational statuses 
were secondary school were less likely to practice safe sex 
than HIV patients whose educational statuses were college/
university. HIV patients whose monthly income was in 
between 901-1 300 ETH Birr were less likely to practice safe 
sex than HIV patients whose monthly income was above 1300 
ETH Birr. Regarding a unit increase in total score of self-
efficacy on safe sex practice, the odds of practicing safe sex 
was increased by 2.0. This result is similar when compared 
with a study conducted in Nigeria[14].
   The HIV patients had lower CD4 counts. Future study 
should be conducted on quality of life among HIV patients. 
The HIV patients had very high HIV disclosure status. The 
HIV patients had high self-efficacy on disclosure, safe sex 
and treatment adherence. This good practice should be 
promoted and enhanced in different part of Ethiopia. 
   Self-efficacy and safe sex practices had direct 
relationship. There are significant associations between 
gender and self-efficacy on making an effective disclosure 
decision; self-efficacy on safe to disclosure; self-efficacy 
on safe sex practice; self-efficacy on refusal of unsafe sex 
and self-efficacy on treatment adherence. While designing 
self- efficacy program for HIV patients, segmentation of 
audience (male and female) is very curial point to achieve 
the planned objective.
   The HIV patients had low awareness about their parents 
HIV status. Future effort should be made on awareness 
level about their parents HIV status. Marital status about 
HIV patient’s educational statuses, monthly income self-
efficacy on safe to disclosure and self-efficacy on safe sex 
practice were independent predictors of safe sex practices.
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